1. Home
  2. IT vs EXAS Comparison

IT vs EXAS Comparison

Compare IT & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gartner Inc.

IT

Gartner Inc.

HOLD

Current Price

$231.46

Market Cap

16.8B

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$102.25

Market Cap

19.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IT
EXAS
Founded
1979
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.8B
19.3B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
IT
EXAS
Price
$231.46
$102.25
Analyst Decision
Hold
Buy
Analyst Count
10
19
Target Price
$309.67
$84.27
AVG Volume (30 Days)
823.6K
2.1M
Earning Date
02-03-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
11.49
N/A
Revenue
$6,459,775,000.00
$3,082,033,000.00
Revenue This Year
$6.71
$19.40
Revenue Next Year
$3.35
$13.51
P/E Ratio
$20.63
N/A
Revenue Growth
5.24
14.47
52 Week Low
$221.16
$38.81
52 Week High
$584.01
$102.66

Technical Indicators

Market Signals
Indicator
IT
EXAS
Relative Strength Index (RSI) 44.21 78.48
Support Level $221.16 $102.00
Resistance Level $252.63 $102.66
Average True Range (ATR) 8.14 0.32
MACD -1.52 -0.52
Stochastic Oscillator 33.78 66.38

Price Performance

Historical Comparison
IT
EXAS

About IT Gartner Inc.

Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: